Table 4. Prediction of lymph node metastases based on curettage histology, and status for sL1CAM in preoperative blood samples in 299 lymph node sampled endometrial cancer patients.
| Variable | Na | Univariate OR | 95% CI | P | Multivariate OR | 95% CI | P |
|---|---|---|---|---|---|---|---|
|
Curettage histologyb | |||||||
| Low risk | 224 | 1 | 1 | ||||
| High risk | 75 | 5.83 | 2.79–12.22 | <0.001 | 5.21 | 2.46–11.06 | <0.001 |
|
sL1CAM blood level | |||||||
| Low | 242 | 1 | 1 | ||||
| High | 57 | 2.96 | 1.38–6.31 | 0.005 | 2.25 | 1.01–5.02 | 0.048 |
Abbreviations: CI=confidence interval; OR=odds ratio; sL1CAM= soluble L1 cell adhesion molecule.
a
Only patients with data available for all variables included in the multivariate logistic regression analysis are included in the univariate analysis (N=299).
b
Curettage histological risk classification, low risk (benign, hyperplasia or endometrioid grades 1–2) or high risk (non-endometrioid or endometrioid grade 3).